ORM Evidence

Filings / Booz Allen Hamilton

BOOZ ALLEN HAMILTON INC

Federal contract award, Booz Allen Hamilton, $409,651

Key CONT_AWD_75F40120F19036_7524_HHSF223201510027B_7524. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 194 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/booz-allen-hamilton/CONT_AWD_75F40120F19036_7524_HHSF223201510027B_7524
At the source https://www.usaspending.gov/award/CONT_AWD_75F40120F19036_7524_HHSF223201510027B_7524
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:53:53Z
Content hash a40e0246a4dfae74cec0a041150e3e3aa29495b8355d8d84314f843f296a6b27

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

VersionAmountChangeOccurredPublishedRetrievedHow it arrivedContent hash
1
current
$409,651first versionJuly 26, 2020February 23, 20262026-09-05T00:53:53Zhistorical sweepa40e0246a4df

Archived copy

https://web.archive.org/web/20261002212314/https://www.usaspending.gov/award/CONT_AWD_75F40120F19036_7524_HHSF223201510027B_7524 captured by this system, October 2, 2026

What the amount is made of

3 recorded actions, so the amount is the award's current total across all of them. 1 of them obligated money. Measured 2026-10-14, when USAspending reported a total obligation of $409,651.

Action dateModificationTypeObligatedDescription as recorded
February 23, 2026P00002OTHER ADMINISTRATIVE ACTIONno moneyFIRM FIXED PRICE AWARD PIPELINE ASSESSMENT FOR PHARMACODYNAMIC BIOMARKERS IN BIOSIMILAR DEVELOPMENT FDA THREE-WAY-MATCHING INVOICE CLAUSE-COR: ROBERTJ.PARKER@FDA.HHS.GOV THE PURPOSE OF THIS MODIFICATION IS TO REVISE THE STATEMENT OF WORK IN ACCO
September 30, 2020P00001OTHER ADMINISTRATIVE ACTIONno moneyFIRM FIXED PRICE AWARD PIPELINE ASSESSMENT FOR PHARMACODYNAMIC BIOMARKERS IN BIOSIMILAR DEVELOPMENT FDA THREE-WAY-MATCHING INVOICE CLAUSE-COR: ROBERTJ.PARKER@FDA.HHS.GOV THE PURPOSE OF THIS MODIFICATION IS TO REVISE THE DELIVERABLE SCHEDULE (ATT
July 26, 2020basenot on file+$409,651FIRM FIXED PRICE AWARD PIPELINE ASSESSMENT FOR PHARMACODYNAMIC BIOMARKERS IN BIOSIMILAR DEVELOPMENT FDA THREE-WAY-MATCHING INVOICE CLAUSE-COR: ROBERTJ.PARKER@FDA.HHS.GOV

Last refreshed November 4, 2026 at 2:31 PM UTC.